NNOX - Nano-X Imaging Ltd.
NASDAQ
->
Healthcare
->
Medical Devices
Neve Ilan,
Israel
Type: Equity
NNOX price evolution
NNOX
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39.03 | $44.97 | $56.42 | |
| Short term investments | $24.88 | $28.04 | $26.01 | |
| Net receivables | $1.49 | $1.51 | $1.44 | $1.48 |
| Inventory | $1.03 | $0.96 | $2.95 | $2.36 |
| Total current assets | $60.44 | $69.63 | $79.03 | $88.64 |
| Long term investments | $0.32 | $0.32 | $0.33 | |
| Property, plant & equipment | $48.62 | $48.57 | $46.7 | $46.92 |
| Goodwill & intangible assets | $75.3 | $77.95 | $80.61 | |
| Total noncurrent assets | $126.09 | $126.84 | $130.01 | |
| Total investments | $25.21 | $28.37 | $26.33 | |
| Total assets | $183.94 | $195.72 | $205.88 | $218.65 |
| Current liabilities | ||||
| Accounts payable | $1.33 | $1.57 | $1.86 | $3.3 |
| Deferred revenue | $0.54 | $0.5 | $0.54 | |
| Short long term debt | $4.04 | $4.22 | $4.35 | |
| Total current liabilities | $13.03 | $13.5 | $13.61 | $15.52 |
| Long term debt | $3.68 | $3.82 | $4.04 | |
| Total noncurrent liabilities | $7.09 | $7.31 | $7.61 | |
| Total debt | $7.72 | $8.04 | $8.4 | |
| Total liabilities | $20.05 | $20.59 | $20.92 | $23.13 |
| Shareholders' equity | ||||
| Retained earnings | -$359.69 | -$346.05 | -$332.47 | -$320.23 |
| Other shareholder equity | $0.01 | -$0.05 | -$0.12 | -$0.3 |
| Total shareholder equity | $175.13 | $184.96 | $195.51 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $56.42 | $38.46 | $66.64 | $213.47 |
| Short term investments | $26.01 | $39.16 | $22.07 | |
| Net receivables | $1.48 | $0.98 | $1.05 | |
| Inventory | $2.36 | |||
| Total current assets | $88.64 | $82.46 | $94.86 | $219.79 |
| Long term investments | $0.33 | $25.26 | $67.97 | $0.32 |
| Property, plant & equipment | $46.92 | $44.7 | $39.16 | $15.38 |
| Goodwill & intangible assets | $80.61 | $98.64 | $160.12 | |
| Total noncurrent assets | $130.01 | $171.47 | $268.31 | $16.36 |
| Total investments | $26.33 | $64.42 | $90.04 | $0.32 |
| Total assets | $218.65 | $253.93 | $363.17 | $236.15 |
| Current liabilities | ||||
| Accounts payable | $3.3 | $3.62 | $3.13 | $0.43 |
| Deferred revenue | $0.54 | $0.58 | $0.66 | |
| Short long term debt | $4.35 | $0.74 | $1.03 | $0.52 |
| Total current liabilities | $15.52 | $25.07 | $52.75 | $4.48 |
| Long term debt | $4.04 | $3.88 | $4.75 | $0.92 |
| Total noncurrent liabilities | $7.61 | $12.18 | $18.27 | $0.92 |
| Total debt | $8.4 | $4.62 | $5.77 | $1.44 |
| Total liabilities | $23.13 | $37.25 | $71.02 | $5.4 |
| Shareholders' equity | ||||
| Retained earnings | -$320.23 | -$259.46 | -$146.21 | -$84.42 |
| Other shareholder equity | -$0.3 | -$1.97 | -$0.61 | |
| Total shareholder equity | $195.51 | $216.68 | $292.15 | $230.75 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.7 | $2.55 | $2.4 | |
| Cost of revenue | $5.55 | $4.61 | $4.11 | |
| Gross Profit | -$2.85 | -$2.05 | -$1.72 | |
| Operating activities | ||||
| Research & development | $4.81 | $5.22 | $6.81 | |
| Selling, general & administrative | $6.75 | $5.84 | $4.83 | |
| Total operating expenses | $11.65 | $11.07 | $8.97 | |
| Operating income | -$14.51 | -$13.13 | -$10.69 | |
| Income from continuing operations | ||||
| EBIT | -$13.65 | -$12.34 | -$10.69 | |
| Income tax expense | -$0.08 | -$0.09 | -$0.08 | |
| Interest expense | -$0.36 | |||
| Net income | ||||
| Net income | -$13.57 | -$12.24 | -$10.25 | |
| Income (for common shares) | -$13.57 | -$12.24 | -$10.25 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $9.9 | $8.58 | $1.3 | |
| Cost of revenue | $16.5 | $15.46 | $2.82 | |
| Gross Profit | -$6.59 | -$6.88 | -$1.51 | |
| Operating activities | ||||
| Research & development | $26.05 | $26.51 | $17.12 | $9.21 |
| Selling, general & administrative | $28.44 | $45.63 | $41.74 | $34.71 |
| Total operating expenses | $56 | $110.83 | $60.05 | $43.92 |
| Operating income | -$62.59 | -$117.71 | -$61.56 | -$43.92 |
| Income from continuing operations | ||||
| EBIT | -$62.77 | -$117.71 | -$61.56 | -$43.92 |
| Income tax expense | -$0.34 | -$3.68 | -$0.05 | |
| Interest expense | -$1.65 | -$0.79 | $0.29 | -$0.11 |
| Net income | ||||
| Net income | -$60.78 | -$113.24 | -$61.8 | -$43.81 |
| Income (for common shares) | -$60.78 | -$113.24 | -$61.8 | -$43.81 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$13.57 | -$12.24 | -$10.25 | |
| Operating activities | ||||
| Depreciation | $2.93 | $2.94 | $3.1 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.1 | $1.48 | $1.86 | |
| Total cash flows from operations | -$8.49 | -$9.45 | -$12.51 | |
| Investing activities | ||||
| Capital expenditures | -$0.85 | -$0.14 | -$0.53 | |
| Investments | $3.37 | -$1.92 | $2.8 | |
| Total cash flows from investing | $6.19 | $2.52 | -$2.06 | $2.27 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $0.02 | $0.03 | |
| Net borrowings | ||||
| Total cash flows from financing | $1.67 | $0.02 | $0.02 | $0.03 |
| Effect of exchange rate | $0.03 | $0.01 | $0.03 | -$0.15 |
| Change in cash and equivalents | -$18.18 | -$5.94 | -$11.46 | -$10.36 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$60.78 | -$105.24 | -$61.8 | -$43.81 |
| Operating activities | ||||
| Depreciation | $11.81 | $11.51 | $0.21 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $6.84 | $18.62 | $24.78 | |
| Total cash flows from operations | -$44.78 | -$43.38 | -$21.49 | |
| Investing activities | ||||
| Capital expenditures | -$3.3 | -$7.17 | -$13.94 | |
| Investments | $38.74 | $21.78 | ||
| Total cash flows from investing | $35.43 | $14.61 | -$13.94 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $28.04 | $0.95 | $240.99 | |
| Net borrowings | -$0.14 | |||
| Total cash flows from financing | $27.25 | $0.8 | $240.99 | |
| Effect of exchange rate | -$0.06 | -$0.27 | ||
| Change in cash and equivalents | $17.85 | -$28.24 | $205.57 | |
News
Fundamentals
| Market cap | $472.27M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 58.52M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.12 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 4.64 |
| Quick ratio | 4.56 |